Published in Diabetes Week, February 19th, 2007
Awardees will have access to the DRC's in silico modeling and biosimulation capabilities, allowing them an unparalleled ability to investigate the onset, progression, and treatment of diabetes.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.